Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1882871생성일: 2026년 10월 26일
N-vinyl-2-pyrrolidone → 1-[3-(2-Piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one
https://huagongshe.com/reaction/1882871
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | N-vinyl-2-pyrrolidone | HCID 6917 | — |
| 반응물 | Sodium Hypochlorite | HCID 23665760 | — |
| 반응물 | 3-Piperidin-1-yl-propionaldehyde oxime | HCID 74057870 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 생성물 | 1-[3-(2-Piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one | HCID 10015727 | 45% |
반응 단계
To a solution of 646 μL (1.5 equivalent) of N-vinyl-pyrrolidin-2-one in 5 mL of chloroform, a biphasic solution of 7.4 mL (3.2 equivalents) of 13% Clorax (NaOCl) and a solution of 629.3 mg (4.03 mmol) of 3-piperidin-1-yl-propionaldehyde oxime compound prepared in Example 2 in 5 mL of chloroform were added slowly over 15 minutes with cooling to 0° C. and stirring vigorously. After reacting at room temperature overnight, the reaction mixture was extracted with chloroform three times, washed with a saturated aqueous solution of sodium carbonate twice following water once, dried over sodium sulfate, filtered and then concentrated under reduced pressure. The concentrate was purified by separation with silica gel column chromatography using chloroform/methanol (30:1) as eluent to obtain 477.4 mg (45% yield) of 1-[3-(2-piperidin-1-yl-ethyl)-4,5-dihydro-isoxazol-5-yl]-pyrrolidin-2-one. Subsequently, 1:1 acid addition salt with oxalic acid was obtained from the diethyl ether solution.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06759419B2 |
|---|
| 출처 데이터셋 | uspto-grants-2004_07 |
|---|
| ORD ID | ord-c215c43c539b429eb0c01714f31ab002 |
|---|
| 출처 메모 | uspto-grants-2004_07 |
|---|